Summer Workshop: Fragment-based Compound Evolution

webinar

Wed, 21 Jul 2021, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

Summer Workshop: Fragment-based Compound Evolution

Fragment-based drug design (FBDD) receives more and more attention in the scientific community. The the fifth fragment-derived drug, sotorasib, received approval by the FDA for the treatment of non-small cell lung cancer this year. In this workshop we will discuss strategies around FBDD with recent med-chem use cases and how to utilize resources for lead optimization and idea generation. by thinking outside the box. Learn how to evolve a weak binder to a full-fledged drug candidate.

Participants can request a certificate of attendance.

Current news

category
Events
Upcoming Lunch Workshops in San Diego & San Francisco
July 4, 2025 16:30 CEST
Why not make good use of an extended lunch break for a change? Join the BioSolveIT team for two informal lunch events in San Diego and San Francisco, featuring a short workshop on efficient strategies for exploring chemical space and processing large molecular datasets — key topics in early-stage drug...
Read on
category
Events
Announcing BioSolveIT's DrugSpace Symposium 2025: Bridging Science
June 26, 2025 09:43 CEST
We are pleased to announce the fourth edition of the BioSolveIT DrugSpace Symposium, taking place on September 24–25, 2025. This year’s theme, “Bridging Science,” highlights the growing importance of interdisciplinary collaboration in driving innovation across the drug discovery landscape. As the field evolves, it becomes increasingly clear that real progress...
Read on
Psst... Are You Following Us Yet? Follow the Science (and a Bit More)
June 25, 2025 08:44 CEST
There’s a lot going on behind the scenes—ideas taking shape, tools evolving, science in motion. And while the website tells you what our software does, our social media gives you a look at how it lives. We’re active on LinkedIn, BlueSky, and YouTube, sharing everything from scientific snapshots to educational...
Read on